Targeting TDP-43 with protein kinase inhibitors: a effective and measurable therapy for ALS
Coordinator: Ana Martinez. IP IMDEA Nanociencia: Valle Palomo
-
Funding :
Fundación La Caixa - CaixaResearch Health call in collaboration with the Fundación Luzón
-
Duration: 2021 - 2025